Lumason
Total Payments
$372,534
Transactions
464
Doctors
329
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $303,337 | 152 | 100 |
| 2023 | $23,449 | 124 | 86 |
| 2022 | $27,995 | 101 | 84 |
| 2021 | $13,294 | 44 | 41 |
| 2020 | $4,460 | 43 | 38 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $136,091 | 37 | 36.5% |
| Grant | $90,000 | 3 | 24.2% |
| Consulting Fee | $85,847 | 18 | 23.0% |
| Honoraria | $25,742 | 10 | 6.9% |
| Food and Beverage | $18,280 | 389 | 4.9% |
| Travel and Lodging | $11,361 | 4 | 3.0% |
| Royalty or License | $5,214 | 3 | 1.4% |
Payments by Type
General
$236,444
427 transactions
Research
$136,091
37 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Added value of gadopiclenol-enhanced MR imaging compared to noncontrast MR imaging in Crohns disease. | Bracco Diagnostics Inc. | $64,050 | 0 |
| Lumason Bolus vs Infusion | Bracco Diagnostics Inc. | $49,993 | 0 |
| LYSHCHIK_CONTRAST ENHANCED ULTRASOUND EVALUATION OF FOCAL LIVER LESIONS IN PATIENTS WITH CIRRHOSIS OR OTHER RISK FACTORS FOR DEVELOPING HCC | BRACCO DIAGNOSTICS INC. | $2,868 | 1 |
| Multi-Modality Detection of RCC Recurrence Post-Ablation | Bracco Diagnostics Inc. | $2,295 | 0 |
| Development of Contrast Enhanced Ultrasound Video Urodynamics in Pediatric Urology | Bracco Diagnostics Inc. | $1,969 | 0 |
| 2D and 3D Contrast Enhanced Ultrasound of Chemoembolization | Bracco Diagnostics Inc. | $1,147 | 0 |
| Contrast-enhanced Ultrasound Evaluation of Liver Nodules in Patients Following the Fontan Procedure | Bracco Diagnostics Inc. | $860.49 | 0 |
| Feasibility and Utility of Intraoperative Contrast-Enhanced Ultrasound to Evaluate Femoral Head Perfusion in Infants with Development Hip Dysplasia after Closed Reduction | Bracco Diagnostics Inc. | $860.49 | 0 |
| CHUNG_CONTRAST-ENHANCED ULTRASONOGRAPHY FOR THE EVALUATION OF URETHRAL STRICTURE DISEASE | BRACCO DIAGNOSTICS INC. | $574.00 | 1 |
| DILLMANN_CONTRAST-ENHANCED ULTRASOUND EVALUATION OF BOWEL WALL INFLAMMATION IN PEDIATRIC CROHNS DISEASE: COMPARISON TO CT AND MRI ENTEROGRAPHY | BRACCO DIAGNOSTICS INC. | $574.00 | 1 |
| HWANG_EVALUATION OF BOWEL PERFUSION WITH CONTRAST-ENHANCED ULTRASOUND IN NECROTIZING ENTEROCOLITIS | BRACCO DIAGNOSTICS INC. | $574.00 | 1 |
| Contrast Enhanced Ultrasound Evaluation of Bowel Wall Inflammation in Pediatric Crohn's Disease: Comparison to CT and MRI Enterography | Bracco Diagnostics Inc. | $573.66 | 0 |
| Genicular Artery Embolization for the Treatment of Persistent Knee Pain Following Joint Replacement Surgery | Bracco Diagnostics Inc. | $573.66 | 0 |
| Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early State ER+ Breast Cancer | Bracco Diagnostics Inc. | $573.66 | 0 |
Top Doctors Receiving Payments for Lumason — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Cardiovascular Disease | Philadelphia, PA | $191.81 | 1 |
| , MD | Emergency Medicine | Orange, CA | $191.81 | 1 |
| , MD | Emergency Medicine | Charlotte, NC | $191.81 | 1 |
| , MD | Emergency Medicine | Newark, DE | $191.81 | 1 |
| , MD | Emergency Medicine | Rochester, MN | $191.81 | 1 |
| , MD | Diagnostic Radiology | Rochester, MN | $191.81 | 1 |
| , MD | Emergency Medicine | Akron, OH | $191.81 | 1 |
| , M.D | Emergency Medicine | Newark, DE | $191.81 | 1 |
| , MD, MPH | Cardiovascular Disease | Orange, CA | $191.81 | 1 |
| , MD | Pediatric Cardiology | Aurora, CO | $162.37 | 2 |
| , M.D | Pediatric Cardiology | Cincinnati, OH | $160.12 | 2 |
| , MD | Student in an Organized Health Care Education/Training Program | Columbus, OH | $149.60 | 1 |
| , MD | Diagnostic Radiology | Dallas, TX | $146.52 | 6 |
| , MD | Cardiovascular Disease | Chicago, IL | $144.02 | 1 |
| , MD | Cardiovascular Disease | Maywood, IL | $144.01 | 1 |
| , M.D | Pediatric Cardiology | Chicago, IL | $144.01 | 1 |
| , M.D, , MPH | Internal Medicine | Maywood, IL | $144.01 | 1 |
| , M.D | Cardiovascular Disease | Chicago, IL | $144.01 | 1 |
| , DO | Diagnostic Radiology | Long Beach, CA | $137.08 | 1 |
| , M.D | Cardiovascular Disease | Dallas, TX | $136.51 | 1 |
| , M.D | Cardiovascular Disease | Aurora, CO | $136.51 | 1 |
| , M.D | Cardiovascular Disease | Pittsburgh, PA | $136.20 | 2 |
| , MD | Cardiovascular Disease | Pittsburgh, PA | $125.96 | 3 |
| , APRN | Family | Leitchfield, KY | $125.00 | 1 |
| , M.D | Cardiovascular Disease | Rochester, MN | $123.82 | 1 |
Ad
Manufacturing Companies
- Bracco Diagnostics Inc. $333,541
- BRACCO DIAGNOSTICS INC. $38,994
Product Information
- Type Drug
- Total Payments $372,534
- Total Doctors 329
- Transactions 464
About Lumason
Lumason is a drug associated with $372,534 in payments to 329 healthcare providers, recorded across 464 transactions in the CMS Open Payments database. The primary manufacturer is Bracco Diagnostics Inc..
Payment data is available from 2020 to 2024. In 2024, $303,337 was paid across 152 transactions to 100 doctors.
The most common payment nature for Lumason is "Unspecified" ($136,091, 36.5% of total).
Lumason is associated with 14 research studies, including "Added value of gadopiclenol-enhanced MR imaging compared to noncontrast MR imaging in Crohns disease." ($64,050).